Cel Sci Corporation (CVM)

[lightrock]

Fact is that given the 5 year survival we would be expecting 344 event by May 2018 if Multikine were just as effective as SOC. But as we have not yet reached the 298 mark this would indicate benefit from Multikine.

Looking on the spreadsheet, if you do this guy's math
https://seekingalpha.com/article/4170868-cel-sci-simple-math-appears-imply-phase-3-success

And you fix that guy's math into the 3/7, 3/7, 1/7th, and the two 3/7th groups compare because you checked with Cel-Sci Investor Relations for the truth of it...

Then as of May 2018 there would be between 294 to 308 events.

( If as you suggest there are 344 events already then the study is over and where is the news ? - so... that math is not right and if I were a mathematician professionally I would say something scathing about even mentioning it because it is obviously wrong )

If you do my math ( maybe bad but certainly not as bad ), which starts with that guy's math and then fixes it, not only with the right groups, but ALSO with published data from The Oncologist on SOC numbers AND you consider a 42% "response rate" in those injected...

Then the projection is that there are 200 events and 593 remaining living as of May 30 2018.

( you can add about 28 to my event numbers - recently they brought back the 2011-2013 data )